Articles

A physician explains that the sale of nonprescription cosmeceuticals from a dermatology office should be done in a manner that is educational but non-threatening to patients.

Stanford University Medical School established a positive partnership with a pharmaceutical company to offer an industry-sponsored resident elective course in a way that minimizes conflict of interest and has been accepted by the ACGME.

A physician argues that pharmaceutical industry support for residency programs creates a conflict of interest and compromises the educational integrity of the programs.

Physicians need to be aware of and guard against the liability risks of having nonphysician clinicians provide services that do not meet the standard of care of the practice due to the staff member's inadequate experience or supervision.

The basic guidelines for identifying a cutaneous melanoma are outlined.

The practice of informed consent has played a critical role in the evolution of the use of isotretinoin therapy and appropriate warning labels.

Two physicians give an overview of the iPledge program and discuss the problematic aspects of the program for physicians who prescribe isotretinoin and their patients.

A physician discusses the trend toward medical students selecting medical specialties based on the lifestyle they provide.

A historical look at dermatological testing and the regulations that have been enacted to protect the patients who test skin care products.

A bioethicist argues that children with Down syndrome should not be subjected to cosmetic surgery to change their appearance unless they are at the age and have the capacity to make the decision for themselves.